[1]
“EFFICIENCY OF ADJUVANT XELOX CHEMOTHERAPY FOR PATIENTS WITH RESECTABLE GASTRIC IN RUSSIA (SINGLE INSTITUTION RETROSPECTIVE STUDY)”, Вопр. онкол., vol. 65, no. 2, pp. 256–262, Feb. 2019, doi: 10.37469/0507-3758-2019-65-2-256-262.